Incyte Announces Multiple Abstracts from its Dermatology Portfolio have been Accepted for Presentation at the 2022 American Academy of Dermatology (AAD) Annual Meeting

18.03.2022 - Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming American Academy of Dermatology (AAD) Annual Meeting, held March 25-29, 2022, in Boston. New 52-week data ... Seite 1

Related Keywords

United States ,Jim Lee ,Mental Health ,Group Vice ,Group Vice President ,Week Phase ,Late Breaking Research ,Ruxolitinib Cream ,Atopic Dermatitis ,Anatomic Region ,Pooled Analysis From Two Randomized Phase ,Ev Phase ,Pigmentary Disorders ,Patient Demographics ,Baseline Clinical Characteristics ,Findings From ,Incyte ,